Hand Motor Rehabilitation Using a Wearable Robotic Device (WRL HX MCP)

NCT05155670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-03-06

No results posted yet for this study

Summary

The purpose of this pilot study is to assess the safety and usability of the WRL HX MCP medical device, a prototypal robotic system for metacarpophalangeal joint mobilization. WRL HX MCP was developed by the Wearable Robotics Laboratory of Scuola Superiore Sant'Anna in a project funded by and in collaboration with INAIL, to fulfil the needs of patients with post-traumatic hand stiffness.

Conditions

  • Hand Injuries

Interventions

DEVICE

WRL HX MCP

WRL HX MCP is a non CE marked class IIa medical device designed for clinical application in hand rehabilitation; it consists in a cable-driven robotic MCP orthosis providing flexion-extension of the metacarpo-phalangeal joint. WRL HX MCP features and a series-elastic actuators (SEA) architecture for compliant actuation of MCP flexion-extension and a self-aligning mechanism to absorb human/robot joint axes misplacement. Exoskeleton module is mounted on a dorsal hand support and connected to its electronic box through wires.

Sponsors & Collaborators

  • Scuola Superiore Sant'Anna di Pisa

    collaborator OTHER
  • Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro

    lead OTHER

Principal Investigators

  • Elisa Taglione, MD · INAIL - Centro di Riabilitazione Motoria di Volterra

  • Simona Crea, PhD · The BioRobotics Institute, Scuola Superiore Sant'Anna

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-26
Primary Completion
2022-09-25
Completion
2023-03-25

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05155670 on ClinicalTrials.gov